ChainCatcher news, the decentralized science (DeSci) ecological platform LAVO Protocol announced the signing of a strategic memorandum of understanding with the international investment company Almak Group, led by Sheikh Ali Rashed Ali Saeed Al Maktoum of the Dubai royal family. Both parties will work together to promote the construction of longevity medical research infrastructure and will deeply expand LAVO's “biological bridge” ecosystem into the Middle East and Asian markets.
According to reports, LAVO Protocol is the world's first execution layer that directly connects decentralized liquidity with physical biotechnology, with its core system encompassing ExoBiome's exclusive technology and GMP-grade industrial manufacturing capabilities. The project is led by regenerative medicine expert Dr. Jac and exosome technology authority Dr. Anton Philip Battiade Giacomo. By tokenizing real-world biotechnology and launching the first flagship token $EXO, LAVO aims to leverage Web3 to empower biopharmaceutical R&D, significantly accelerating the commercialization process and global delivery of longevity therapies.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
